PR 3.4 Supplementary prospectus
Supplementary prospectus
Section 87G of the Act provides that:
(1) |
Subsection (2) applies if, during the relevant period, there arises or is noted a significant new factor, material mistake or inaccuracy relating to the information included in a prospectus approved by the [ FSA]. |
|
(2) |
The person on whose application the prospectus was approved must, in accordance with prospectus rules, submit a supplementary prospectus containing details of the new factor, mistake or inaccuracy to the [FSA] for its approval. |
|
(3) |
The relevant period begins when the prospectus is approved by the [FSA] and ends – |
|
(a) |
with the closure of the offer of the transferable securities to which the prospectus relates; or |
|
(b) |
when trading in those securities on a regulated market begins. |
|
(4) |
"Significant" means significant for the purposes of making an informed assessment of the kind mentioned in section 87A(2). |
|
(5) |
Any person responsible for the prospectus who is aware of any new factor, mistake or inaccuracy which may require the submission of a supplementary prospectus in accordance with subsection (2) must give notice of it to – |
|
(a) |
the issuer of the transferable securities to which the prospectus relates, and |
|
(b) |
the person on whose application the prospectus was approved. |
|
(6) |
A supplementary prospectus must provide sufficient information to correct any mistake or inaccuracy which gave rise to the need for it. |
|
(7) |
Subsection (1) applies also to information contained in any supplementary prospectus published under this section. |
|
Amendments to summary
A supplementary prospectus must also if necessary include an amendment or supplement to the summary, and any translations of the summary, to take into account the new information. [ Note: article 16.1 PD ]
Note: Section 87Q(4) of the Act sets out the rights of investors to withdraw their acceptances after a supplementary prospectus is published.